Ligand validation:7CL6

XXX: (1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside

XXX is a Ligand Of Interest in 7CL6 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7CL6_XXX_C_303	81%	67%	0.113	0.964	0.49	0.78	-	1	0	0	100%	1
7CL6_XXX_A_303	75%	69%	0.128	0.961	0.47	0.72	-	-	0	0	100%	1
7CL6_XXX_E_303	57%	49%	0.142	0.916	0.65	1.31	-	5	0	0	100%	1
7CL6_XXX_F_303	57%	67%	0.148	0.922	0.49	0.79	-	1	0	0	100%	1
7CL6_XXX_B_303	19%	65%	0.232	0.828	0.65	0.68	-	1	1	0	100%	1
7CL6_XXX_D_303	6%	63%	0.32	0.763	0.55	0.86	-	-	0	0	100%	1
6S0V_XXX_F_306	39%	44%	0.23	0.94	0.59	1.53	-	7	0	0	100%	0.7
5Z8K_XXX_A_502	61%	40%	0.122	0.91	1.23	1.11	2	3	0	0	100%	1
2ET8_XXX_B_51	51%	25%	0.197	0.954	1.87	1.21	7	4	1	0	100%	1
2FCX_XXX_A_101	37%	67%	0.161	0.859	0.43	0.83	-	2	0	0	100%	1
6E0D_XXX_A_502	23%	21%	0.241	0.866	1.06	2.23	2	10	3	0	100%	0.6

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.